Movatterモバイル変換


[0]ホーム

URL:


Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Atypon full text link Atypon Free PMC article
Full text links

Actions

Share

Review
.2008 Jun 7;275(1640):1231-41.
doi: 10.1098/rspb.2007.1673.

Revealing the paradox of drug reward in human evolution

Affiliations
Review

Revealing the paradox of drug reward in human evolution

Roger J Sullivan et al. Proc Biol Sci..

Abstract

Neurobiological models of drug abuse propose that drug use is initiated and maintained by rewarding feedback mechanisms. However, the most commonly used drugs are plant neurotoxins that evolved to punish, not reward, consumption by animal herbivores. Reward models therefore implicitly assume an evolutionary mismatch between recent drug-profligate environments and a relatively drug-free past in which a reward centre, incidentally vulnerable to neurotoxins, could evolve. By contrast, emerging insights from plant evolutionary ecology and the genetics of hepatic enzymes, particularly cytochrome P450, indicate that animal and hominid taxa have been exposed to plant toxins throughout their evolution. Specifically, evidence of conserved function, stabilizing selection, and population-specific selection of human cytochrome P450 genes indicate recent evolutionary exposure to plant toxins, including those that affect animal nervous systems. Thus, the human propensity to seek out and consume plant neurotoxins is a paradox with far-reaching implications for current drug-reward theory. We sketch some potential resolutions of the paradox, including the possibility that humans may have evolved to counter-exploit plant neurotoxins. Resolving the paradox of drug reward will require a synthesis of ecological and neurobiological perspectives of drug seeking and use.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Data from the US National Survey on Drug Use and Health 2004: drug use in the last year.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Aklillu E, Persson I, Bertilsson L, Johansson I, Rodrigues F, Ingelman-Sundberg M. Frequent distribution of ultrarapid metabolizers of debrisoquine in an Ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles. J. Pharmacol. Exp. Ther. 1996;278:441–446. - PubMed
    1. Aynacioglu A.S, Sachse C, Bozkurt A, Kortunay S, Nacak M, Schröder T, Kayaalp S.O, Roots I, Brockmöller J. Low frequency of defective alleles of cytochrome P450 enzymes 2C19 and 2D6 in the Turkish population. Clin. Pharmacol. Therap. 1999;66:185–193. - PubMed
    1. Baldwin I.T. An ecologically motivated analysis of plant-herbivore interactions in native tobacco. Plant Physiol. 2001;127:1449–1458.doi:10.1104/pp.127.4.1449 - DOI - PMC - PubMed
    1. Bentz J.A, Barbosa P. Effects of dietary nicotine (0.1%) and parasitism by Cotesia congregata on the growth and food consumption and utilization of the tobacco hornworm, Manduca sexta. Entomol. Exp. Appl. 1990;57:1–8.doi:10.1007/BF00349589 - DOI
    1. Bernard S, Neville K.A, Nguyen A.T, Flockhart D.A. Interethnic differences in genetic polymorphisms of CYP2D6 in the U.S. population: clinical implications. Oncologist. 2006;11:126–135.doi:10.1634/theoncologist.11-2-126 - DOI - PubMed

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full text links
Atypon full text link Atypon Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.


[8]ページ先頭

©2009-2025 Movatter.jp